ACIP Approves 2010 Adult Immunization Schedule
The Adult Immunization Schedule for 2010, approved by the Advisory Committee on Immunization Practices (ACIP), includes several changes.
The 2010 schedule, which appears in the Annals of Internal Medicine, most notably includes the following changes regarding human papillomavirus vaccination:
- A bivalent human papillomavirus vaccine (HPV2) was licensed for use in females in Oct. 2009.
- The ACIP recommends vaccination of females aged 19-26 years with either HPV2 or the quadrivalent human papillomavirus vaccine (HPV4).
- HPV4 was licensed for use in males, and the ACIP used a permission recommendation for use of this vaccine in males.
Other changes include revisions to footnotes 5 (mumps, measles, rubella), 6 (influenza), 9 (hepatitis A), 10 (hepatitis B), 11 (meningococcal vaccine), and 12 (haemophilus influnezae type B). Please refer to the updated 2010 Adult Immunization Schedule on the Centers for Disease Control and Prevention (CDC) website for a complete explanation of changes and other informative resources.
The 2010 schedule is approved by the American Academy of Family Physicians (AAFP), American College of Obstetricians (ACOG), and the American College of Physicians (ACP).
Coding Tip: To prevent a claim for immunization services from being rejected, remember to link the proper diagnosis code to the respective CPT® code; and for maximum reimbursement, don’t forget that you can legitimately bill a separate administration charge for each vaccine or immunization.